Diabetes; A Journal of the American Diabetes Association 1993: Vol 42 Index

21 Pages·1993·5.7 MB·English

Subject Index
A in renal cortex from STZ-induced rats, Angiotensin-converting enzyme
[2-'*C]acetate, for measuring 826 inhibitors, effects in normotensive
gluconeogenesis in vivo, limitations Aging model of diabetic nephropathy, 604
in use of, 732 effects of epinephrine in insulin Antioxidants
Acetyl-L-carnitine, correction of secretion and action in humans, MDL 29,311, 1179
electroretinographic deficits in interaction with aging, 307 prevention of diabetes in nonobese
experimental diabetes, 1115 ethanol and carbohydrate metabolism diabetic and multiple-low- dose
Acetylcholine, abnormal in elderly and, 28 $TZ-injected mice by MDL 29,311,
agonist-stimulated cardiac Ala’’®, on polyprotein of 1721
parasympathetic acetylcholine encephalomyocarditis virus, Aorta
release in STZ-induced diabetes, determination of diabetogenicity effects of high glucose concentrations
141 attributable to, 435 and epalrestat on sorbitol! and
Acipimox, metabolic consequences of Albuminuria myo-inositol metabolism in
sustained suppression of free fatty exercise-induced, picotamide cultured rabbit aortic smooth
acids by, in NIDDM, 1559 reduction of, in microalbuminuric muscle cells, 1594
Adenosine triphosphate patients with NIDDM, 178 high glucose reduction of specific
impaired glucose sensitivity of impact on progression of nephropathy binding for D-a-tocopherol in
ATP-sensitive K* channels in in IDDM, 715 endothelial cells of, 1138
B-cells of GK rats, 1446 Alcohol Apolipoprotein B, effects of acute
sulfonylurea- binding sites and carbohydrate metabolism in elderly hyperinsulinemia on VLDL
ATP-sensitive K* channels in a-TC triglyceride and VLDL ApoB
and, 28
glucagonoma and B-TC impairment of glucose production in normal weight and
insulinoma cells, 1760 obese individuals, 833
counterregulation by intake during
Adipocytes Apolipoprotein E, polymorphism
cellular insulin resistance in gestational acute insulin-induced modification of relation of
hypoglycemia in, 1626
diabetes caused by multiple hyperinsulinemia to
Aldose reductase, inhibition of, failure to
defecis in adipocyte glucose hypertriglyceridemia, 1474
transport system, 1773 prevent retinopathy in diabetic and Appeiite, effect of
galactosemic dogs, 820
metformin blockage of downregulation dehydroepiandrosterone on
of cell surface GLUT4 caused by Alkylacyiglycerol, insulin-induced neurotransmitter levels and appetite
chronic insulin treatment of rat generation in rat adipocytes, 988 regulation of obese Zucker rat, 663
adipocytes, 1159 ALX-induced diabetes, correction of Arginine vasopressin, effects in mouse
stimulation of glucose transport, erythrocyte deformability defect in pancreatic B-cells, 914
glucose transporter translocation, ALX-induced diabetic rabbits after Arterioles, impaired myogenic reactivity
and dephosphorylation in treatment with aminoguanidine, 590 in early experimental diabetes, 1226
insulin-resistant rat adipocytes in Amine oxidase, semicarbazide-sensitive, Atherogenesis, accelerated, in NIDDM, 1
vitro by glimepiride, 1852 oxidative deamination of Atrial natriuretic factor, impaired
stimulation of hydrolysis of methylamine by, leading to cytotoxic vasodilator response to atrial
plasmanylinositol- glycan and damage in endothelial cells, 594 natriuretic factor in IDDM, 1454
phosphatidylinosigtloylca-n in rat Amino acids, sensitivity of glucose and Autoantibodies
adipocytes by insulin, 988 amino acid metabolism to insulin in association of faulty major
Adipose tissue, effects of NIDDM, 1868 histocompatibility complex class II
hyperinsulinemia and hyperglycemia Aminoguanidine, correction of I-E expression with autoimmunity
on GLUT4 and hexokinase II MRNA erythrocyte deformability defect in in diverse strains of mice, 1166
and protein in rat skeletal muscle ALX-induced diabetic rabbits after characterization of insulin
and adipose tissue, 922 treatment with, 590 autoantibodies in relatives of
Adrenocorticotropic hormone, Amputations, lower- extremity, incidence, patients with IDDM, 1202
impairment of coronary vascular risk factors, and mortality in correlation of insulitis-caused
reserve and ACh-induced coronary Oklahoma Indian Diabetes Study, redistribution of heat-shock protein
vasodilation in ciabetic patients with 876 HSP60 inside B-cells with
angiographically normal coronary Amyloid polypeptide induction of HSP60
arteries and normal left ventricular influence of islet amyloid polypeptide autoantibodies, 908
systolic function, 1017 and 8-37 fragment of islet amyloid in IDDM, primary recognition of
Advanced glycation end products, polypeptide on insulin release 65,000-M, rather than 67,000M,
immunochemical detection of from perfused rat islets, 330 isoform of glutamic acid
in lens crystallins from STZ-induced regulation in human pancreatic islets, decarboxylase by, 631
diabetic rat, 345 1514 Autoimmune diabetes
DIABETES: VOLUME 42 (1993) PAGE NUMBERS BY ISSUE
January, 1-212 April, 503-636 July, 941-1098 October, 1383-1547
February, 213-366 May, 637-800 August, 1099-1218 November, 1549-1689
March, 367-502 June, 801—940 September, 1219-1382 December, 1691-1882
SUBJECT INDEX 1993
lack of role of complement lytic activity sympathovagal balance in adoptive transfer of BB rat diabetic
in pathogenesis of, in NOD mice, autonomic neuropathy, 1745 syndrome and, 390
1574 Brain adoptive transfer of diabetes into
prevention with lymphotoxin in NOD direction of counterregulation during immunodeficient NOD mice, 44
mice, 398 hypoglycemia by widespread simultaneous coexpression of naive
revelation in adults with brain regions, 1253 and memory lymphocyte markers
non-insulin- dependent onset of effect of maternal diabetes in at diagnosis of IDDM, 127
disease by antibodies to glutamic expression of genes regulating Children
acid decarboxylase, 359 fetal brain glucose uptake, 1487 early exposure to dairy products
Autoimmunity, association of faulty major expression of sodium channel association with increased risk of
histocompatibility complex class |i a,-Subunit related to fetal brain IDDM in Finnish children, 1786
|-E expression with autoimmunity in isoform by human, rodent, and cow's milk and solid foods in infancy
diverse strains of mice, 1166 canine pancreatic B-cells, 1372 and genetic predisposition and
risk of IDDM, 288
Autonomic function, effects of ponalrestat
on, 336 Cc obesity in, time course of increased
Autonomic neuropathy Calcium lipid and decreased glucose
mechanisms of arterial hypotension G-protein specificity in signaling oxidation during early phase of
after therapeutic dose of pathways that mobilize calcium in childhood obesity, 1010
subcutaneous insulin in, 1055 insulin-secreting B-TC3 cells, 1878 CIKVAVS, inhibition of neurite outgrowth
number of bursts of muscle normalization of glucose intolerance by nonenzymatic glycosylation of,
sympathetic nerve activity in IDDM accompanying vitamin D depletion 509
as sign of, 1376 in vivo by, 35 Collagen
relationship between circadian rhythms Calphostin C, sustained recovery of enhancement of glomerular collagen
of blood pressure and Na*-K*-ATPase activity in mouse synthesis in diabetic rats by
sympathovagal balance in, 1745 sciatic nerve and, 257 transforming growth factor-B,,
Autoreactive cells, in IDDM, transcription Carbohydrates 1673
facior jun-B as target of, 626 enhancement of intestinal sugar type IV, effect of high glucose on
transport in diabetic mice, 1579 production by cultured glomerular
metabolism in elderly, effects of epithelial, endothelia!, and
B ethanol on, 28 mesangial cells, 170
BB rat Cardiovascular risk factors, relationship Complement lytic activity, lack of role in
adoptive transfer of diabetic syndrome Of proinsulin and insulin to, in pathogenesis of autoimmune
in, CD8* T-cells and, 390 nondiabetic subjects, 1297 diabetes in NOD mice, 1574
decreased catecholamine secretion Cartilage, insulinlike growth factor Coronary arteries, impairment of
from adrenal medullae of l-resistant state in cartilage of coronary vascular reserve and
chronically diabetic BB-Wistar diabetic rats ameliorated by ACh-induced coronary vasodilation
rats, 862 hypophysectomy, role of metabolism in diabetic patients with
pancreatic islet function in nondiabetic and, 463 angiographically normal coronary
and diabetic BB rats, 1310 Cataracts arteries and normal left ventricular
spontaneously diabetic, enhanced immunochemical detection of systolic function, 1017
glucose metabolism and advanced glycation end products Cyclophosphamide, reversal of tolerance
respiratory burst in peritoneal in lens crystallins from to IDDM induced by CD4 antibodies
macrophages from, 520 $TZ-induced diabetic rat, 345 in nonobese diabetic mice by, 1601
transcription and translation of RT6? mechanisms for D-glucose inhibition of Cyclosporin A, metabolic effects in liver
gene in lymphopenic myo-inositol influx into rat lens, transplant recipients, 1753
diabetes- prone BB rats, 688 1737
Benfluorex Cathepsin, decreased activity of D
amelioration of insulin resistance in rat glomerular cathepsin and Dairy products, early exposure to
by, 457 metalloprotease in STZ-induced association with increased risk of
normalization of hyperglycemia and diabetes in rats, 1425 IDDM in Finnish children, 1786
reversal of hepatic insulin CD4* T-cells cow's milk and solid foods in infancy
resistance in STZ-induced aberrant distribution in recent- onset and genetic predisposition and
diabetic rats by, 564 IDDM patients, 862 risk of IDDM, 288
Blacks, with NIDDM, insulin resistance adoptive transfer of diabetes into Deferoxamine, lack of effect on glucose
syndrome and, 444 immunodeficient NOD mice, 44 homeostasis and insulin secretion in
Blood pressure. See also Hypertension reversal of tolerance to IDDM induced individuals with NIDDM and elevated
arterial by CD4 antibodies in nonobese serum ferritin, 544
impact on progression of diabetic mice by Dehydroepiandrosterone, effects on
nephropathy in IDDM, 715 cyclophosphamide, 1601 neurotransmitter levels and appetite
mechanisms of hypotension after simultaneous coexpression of naive regulation of cbese Zucker rat, 663
therapeutic dose of and memory lymphocyte markers Diabetes Contro! and Complications
subcutaneous insulin in diabetic at diagnosis of IDDM, 127 Trial, 1549
autonomic neuropathy, 1055 CD8* T-cells implications of, 1555
relationship between circadian rhythms aberrant distribution in recent- onset Diabetic complications. See specific
of blood pressure and IDDM patients, 862 disorders
DIABETES: VOLUME 42 (1993) PAGE NUMBERS BY ISSUE
January, 1-212 April, 503-636 July, 941-1098 October, 1383-1547
February, 213-366 May, 637—800 August, 1099-1218 November, 1549-1689
March, 367-502 June, 801-940 September, 1219-1382 December, 1691-1882
SUBJECT INDEX 1993
Diacylglycerol, insulin-induced malformations of, role of substrate acute insulin-induced
generation in rat adipocytes, 988 free-oxygen radical production for hypoglycemia in, 1626
Didecanoyl-L-a- phosphatidylcholine, dysmorphogenesis in cultured rat Ethnicity. See also Race; specific groups
insulin transport across rabbit nasal embryos, 411 association of ethnicity and polycystic
mucosa in vitro induced by, 1032 Encephalomyocarditis virus, Ala’”® on ovary syndrome with independent
Diet polyprotein of, determination of and additive decreases in insulin
carbohydrate enhancement of diabetogenicity attributable to, 435 action in Caribbean-Hispanic
intestinal sugar transport in Endocytosis, inhibition in hepatocytes women, 1462
diabetic mice, 1579 from diabetic rats, 1303 Exendin, cloning and functional
early exposure to dairy products Endothelial barrier, microdialysis expression of human islet GLP-1
association with increased risk of measurement of insulin receptor, exendin-4 and
IDDM in Finnish children, 1786 concentration in subcutaneous exendin-(9-39) and, 1678
cow's milk and solid foods in infancy interstitial fluid, 1469 Exercise, reversal of defect in
and genetic predisposition and Endothelial cells mitrochondrial energy production in
risk of IDDM and, 288 aortic, high glucose reduction of heart of chronically diabetic rat by
fiber in management of diabetes, 503 specific binding for D-a-tocopherol physical training, 682
inducement of insulin resistance in rat in, 1138 Experimental diabetes
by, 457 endothelial cell-binding properties of correction of electroretinographic
reduced motor nerve conduction lymphocytes infiltrated into human deficits in, 1115
velocity and Na*-K*-ATPase diabetic pancreas, 1656 impaired arteriolar myogenic reactivity
activity in rats maintained on glomerular, effect of high glucose on in early experimental diabetes,
L-fucose diet, reversal by type IV collagen production by, 1226
myo-inositol supplementation, 170 Extracellular matrix
1401 modulation of vascular endothelial cell extracellular matrix-containing giant
DNA vasodilatory response by elevated perivascular spaces in thymus of
characterization of CDNA, gene, and D-glucose concentrations, 1497 NOD mouse, 134
chromosomal localization of oxidative deamination of methylamine induction of increased expression of
human skeletal muscle insulin by semicarbazide-sensitive amine extracellular matrix components in
receptor substrate-1, 1041 oxidase leading to cytotoxic rat embryos by maternal diabetes,
islet cell, as target of inflammatory damage in, 594 975
attack by nitric acid, 496 vascular, regulation of glucose
localization of human glucagonlike transport and transporters by F
peptide-1 receptor gene to glucose in, 80 Factor Xla-a,-antitrypsin complex,
chromosome band 6p21 by Endothelin, insulin stimulation of elevation in NIDDM patients with
fluorescence in situ hybridization production and secretion from diabetic nephropathy, 233
and linkage of highly polymorphic bovine endothelial cells, 351 Fasting, insulin-stimulated glucose
simple tandem repeat DNA Endothelium, vascular relaxation uptake and intracellular glucose
polymorphism to other markers on dependent on, in IDDM, 148 metabolism in conscious rats and,
chromosome 6, 1215 Energy production, reversal of defect in 757
simple tandem repeat DNA mitrochondrial energy production in Fatty acids
polymorphism in human glycogen heart of chronically diabetic rat by abnormality of postprandial free fatty
synthase gene, linkage to five physical training, 682 acid kinetics in upper body
markers in chromosome 19q, 930 Epalrestat, effects of high glucose obesity, 1567
DNA damage-inducible genes, increase concentrations and epalrestat on effects of insulin on fatty acid
of expression by genotoxic agents, sorbitol and myo-inositol metabolism reesterification in healthy subjects,
in rat pancreatic islets, 738 in cultured rabbit aortic smooth 1588
Driving, decrements in IDDM during muscle cells, 1594 impairment of glucose
moderate hypoglycemia, 239 Epinephrine, effects on insulin secretion counterregulation by alcohol
Dysmorphogenesis, role of substrate and action in humans, interaction intake during acute
free-oxygen radical production for with aging, 307 insulin-induced hypoglycemia in
dysmorphogenesis in cultured rat Epithelial cells, glomerular, effect of high IDDM, 1626
embryos, 411 glucose on type IV collagen metabolic consequences of sustained
production by, 170 suppression of free fatty acids by
E Erythrocytes, correction of erythrocyte acipimox in NIDDM, 1559
Elderly, carbohydrate metabolism in, deformability defect in ALX-induced Ferritin, lack of effect of deferoxamine
effects of ethanol on, 28 diabetic rabbits after treatment with therapy on glucose homeostasis and
Electroretinography, correction of aminoguanidine, 590 insulin secretion in individuals with
electroretinographic deficits in Escherichia coli, effects of ponalrestat on NIDDM and elevated serum ferritin,
experimental diabetes by neutrophil killing of Escherichia coli 544
acetyl-L-carnitine, 1115 and autonomic function, 336 Fibrinolysis, attenuated, in NIDDM, 1
Embryo Ethanol Fibroblasts, abnormal activation of
induction of increased expression of carbohydrate metabolism in elderly glycogen synthesis in fibroblasts
extracellular matrix components in and, 28 from subjects with NIDDM, evidence
rat embryos by maternal diabetes, impairment of glucose for abnormality specific to glucose
975 counterregulation by intake during metabolism, 583
DIABETES: VOLUME 42 (1993) PAGE NUMBERS BY ISSUE
January, 1-212 April, 503-636 July, 941-1098 October, 1383-1547
February, 213-366 May, 637-800 August, 1099-1218 November, 1549-1689
March, 367-502 June, 801-940 September, 1219-1382 December, 1691-1882
SUBJECT INDEX 1993
Fibronectin simple tandem repeat DNA transforming growth factor-B,,
accumulation by mesangial cells polymorphism to other markers on 1673
grown in high- glucose medium, chromosome 6 and, 1215 Glucagon, loss of potentiating effect of
mediation by protein kinase C, increase of expression of growth arrest hypoglycemia on glucagon
118 and DNA damage-inducible response to hyperaminoacidemia in
mesangial cell prostaglandin release genes gadd 153 and gadd 45 by IDDM, 550
induced by, hyperglycemia and genoioxic agents in rat pancreatic Glucagonlike peptides
PKC inhibition and, 183 islets, 738 cloning and functional expression of
plasma, functional activity in diabetes linkage analysis and molecular human islet GLP-1 receptor,
mellitus, 1606 scanning of glucokinase gene in exendin-4 and exendin-(9-39)
Finnish children, early introduction of NIDDM families, 1238 and, 1678
dairy products associated with linkage of chromosomal marker on 4q glucagonlike peptide-1 and control of
increased risk of IDDM in, 1786 with putative gene determining insulin secretion in normal state
FK 506, metabolic effects in liver maximal insulin action in Pima and NIDDM, 1219
transplant recipients, 1753 Indians, 514 indistinguishable effects of
Free-oxygen radicals, role of substrate localization of IDDM susceptibility glucagonlike peptide-1 7-36
free-oxygen radical production for locus to variable tandem repeat amide and glucagonlike peptide-1
dysmorphogenesis in cultured rat region flanking insulin gene, 1708 7-37 in healthy subjects, 658
embryos, 411 localization of glucagonlike peptide-1
organization of human GLUT2 glucose
Fructose-1,6-biphosphatase, hepatic, transporter gene, 773 receptor gene to chromosome
impaired regulation in New Zealand band 6p21 by fluorescence in situ
risk to IDDM conferred by 5’ insulin
obese mouse model of NIDDM, hybridization and linkage of highly
1731 gene polymorphism independently polymorphic simple tandem
of HLA class II susceptibility, 851
repeat DNA polymorphism to
sequence variations of glucokinase
G other markers on chromosome 6,
gene in Japanese subjects with
Galactosemia, failure of aldose 1215
NIDDM, 1133
reductase inhibition to prevent Glucagonoma, sulfonylurea- binding sites
retinopathy in dogs, 820 simple tandem repeat DNA and ATP-sensitive K* channels in
Galanin, high-affinity GTPase activity in polymorphism in human glycogen a-TC glucagonoma and B-TC
plasma membranes from RINmM5F synthase gene, linkage to five insulinoma cells, 1760
cells stimulated by, 74 markers in chromosome 19q, 930 Glucocorticoids, effect of glucocorticoid
Gamma- aminobutyric acid, production in Genotoxic agents, increase of and growth hormone on proinsulin
rat islets, 1506 expression of growth arrest and levels in humans, 1082
Genetic factors DNA damage-inducible genes gadd Glucokinase
availability of NIDDM diabetic families 153 and gadd 45 by, in rat glucose modulation of activity in rat
for detection of diabetes pancreatic islets, 738 pancreatic B-cells, 199
susceptibility genes, 1536 Gestational diabetes mellitus inhibition of glucose-induced insulin
characterization of cDNA, gene, and cellular insulin resistance caused by secretion through inactivation of
chromosomal localization of multiple defects in adipocyte glucokinase by glyceraldehyde,
human skeletal muscle insulin glucose transport system in, 1773 1003
receptor substrate-1, 1041 glucokinase mutations in, 933 mutations in gestational diabetes
characterization of insulin GK rat mellitus, 933
autoantibodies in relatives of GLUT2 expression and function in Glucokinase gene
patients with IDDM, 1202 B-cells of GK rats with NIDDM, association of polymorphic
decreased risk of IDDM in offspring of dissociation between reductions in microsatellite repeat markers at
mothers who acquire diabetes glucose transport and glucokinase gene locus with
during adrenarchy, 1433 glucose-stimulated insulin NIDDM in Japanese, 1147
distribution of NIDDM in nuclear secretion and, 1065 linkage analysis and molecular
families and, 106 impaired glucose sensitivity of scanning of, in NIDDM families,
early exposure to cow's milk and solid ATP-sensitive K* channels in 1238
foods in infancy and genetic B-cells of, 1446 sequence variations in Japanese
predisposition and risk of IDDM Glimepiride, stimulation of glucose subjects with NIDDM, 1133
and, 288 transport, glucose transporter variants in common form of NIDDM,
effect of maternal diabetes in translocation, and dephosphorylation 579
expression of genes regulating in insulin-resistant rat adipocytes in Gluconeogenesis
fetal brain glucose uptake, 1487 vitro by, 1852 decrease from lactate but not fasting
HLA-DQA1 and DQB1 gene Glomeruli hyperglycemia cr total hepatic
polymorphisms in IDDM patients from diabetic rats, MRNA expression glucose production by inhibition of
from central Italy and their use for of growth factors in, 450 lipolysis in NIDDM, 1694
risk prediction, 1173 effect of high glucose on type IV limitations in use of [2-'*C]acetate for
human glucagonlike peptide-1 collagen production by cultured measuring in vivo, 732
receptor gene, localization to glomerular epithelial, endothelial, Glucose
chromosome band 6p21 by and mesangial celis, 170 amplitude regulation of pulsatile insulin
fluorescence in situ hybridization enhancement of glomerular collagen secretion from individual
and linkage of highly polymorphic synthesis in diabetic rats by pancreatic islets induced by, 670
DIABETES: VOLUME 42 (1993) PAGE NUMBERS BY ISSUE
January, 1-212 April, 503-636 July, 941-1098 October, 1383-1547
February, 213-366 May, 637-800 August, 1099-1218 November, 1549-1689
March, 367—502 June, 801-940 September, 1219-1382 December, 1691-1882
SUBJECT INDEX 1993
calcium channel MRNA expression in reduced sample number for differential regulation by glucose in
rat pancreatic islets, calculation of insulin sensitivity vascular endothelial cells and
downregulation after glucose and glucose effectiveness from smooth muscle cells, 80
infusion and, 948 minimal model, 250, 1635 GLUT2 expression and function in
in children, 1010 role of glucose-6- phosphatase in B-cells of GK rats with NIDDM,
decrease of lipid oxidation and action of insulin on hepatic dissociation between reductions in
gluconeogenesis from lactate but glucose production in rat, 1614 glucose transport and
not fasting hyperglycemia or total upreguiation of myo-inositol transport, glucose-stimulated insulin
hepatic glucose production by compensation for competitive secretion and, 1065
inhibition of lipolysis in NIDDM, inhibition by glucose and, 1119 in human skeletal muscle, in vivo
1694 in vascular endothelial and smooth response to insulin and, 191
effect of elevated concentration on muscle cells, differential regulation induction of insulin resistance of
membrane voltage regulation in of glucose transport and glucose transport and glycogen
retinal capillary pericytes, 1347 transporters by, 80 synthesis in isolated rat skeletal
effect of high glucose on type IV Glucose metabolism muscles by pre-exposure to
collagen production by cultured abnormal activation of glycogen glucosamine, 1333
glomerular epithelial, endothelial, synthesis in fibroblasts from reduction of Na*-dependent glucose
and mesangial cells, 170 subjects with NIDDM, evidence for transport in rat small intestine by
effect on proteoglycans produced by abnormality specific to glucose oral vanadate, 1126
cultured mesangial cells, 1815 metabolism, 583 stimulation by glimepiride in
effects of high concentrations on effect of maternal diabetes in insulin-resistant rat adipocytes in
sorbitol and myo-inositol expression of genes regulating vitro, 1852
metabolism in cultured rabbit fetal brain glucose uptake, 1487 Glucose transporters. See also specific
aortic smooth muscle cells, 1594 enhanced glucose metabolism and transporters
effects on insulin secretion from respiratory burst in peritoneal cellular insulin resistance in gestational
perfused rat islets, 843 macrophages from spontaneously diabetes caused by multiple
fluorescence digital image analysis of diabetic BB rats, 520 defects in adipocyte glucose
glucose-induced [Ca?*]; insulin-stimulated glucose uptake and transport system, 1773
oscillations in mouse islets, 1210 intracellular glucose metabolism in differential regulation by glucose in
impaired glucose sensitivity of conscious rats, fasting and, 757 vascular endothelial cells and
ATP-sensitive K* channels in regulation of glucose uptake and smooth muscle cells, 80
B-cells of GK rats, 1446 metabolism by working muscle, differential regulation of GLUT1 and
impairment of effectiveness by 956 GLUT4 in skeletal muscle of new
repeated low doses of sensitivity to insulin in NIDDM, 1868 model of NIDDM, 1195
streptozocin in dogs, 475 signals derived from glucose glucose modulation of glucose
inhibition of glucose-induced insulin metabolism required for glucose transporter affinity in rat
secretion through inactivation of regulation of pancreatic islet pancreatic B-cells, 199
glucokinase by glyceraldehyde, GLUT2 mRNA and protein, 1273 organization of human GLUT2 glucose
1003 in vivo transporter gene, 773
insulin response to intravenous glucose utilization by individual stimulation of translocation of, by
glucose load during development tissues in virgin and pregnant glimepiride in insulin-resistant rat
of obesity in gold offspring of severely diabetic adipocytes in vitro, 1852
thioglucose-injected mice, 1153 rats, 530 GLUT1, differential regulation in skeletal
lack of effect of deferoxamine therapy in obese and NIDDM subjects with muscle of new model of NIDDM,
on glucose homeostasis and or without hypertension, 764 1195
insulin secretion in individuals with Glucose-6- phosphatase, role in action of GLUT2
NIDDM and elevated serum insulin on hepatic glucose organization of human GLUT2 glucose
ferritin, 544 production in rat, 1614 transporter gene, 773
MDL 29,311 and, 1179 Glucose tolerance signals derived from glucose
mechanisms for D-glucose inhibition of impaired metabolism required for glucose
myo-inositol influx into rat lens, incidence in hypertensive subjects, regulation of pancreatic islet
1737 154 GLUT2 mRNA and protein, 1273
modulation of glucose transporter risk of progression to NIDDM in GLUT4
affinity, glucokinase activity, and South-African Indians with, 556 cellular insulin resistance in gestational
secretory response in rat vitamin D depletion in vivo and, diabetes caused by multiple
pancreatic B-cells, 199 normalization by calcium, 35 defects in adipocyte glucose
modulation of vascular endothelial cell insulin resistance and insulin secretion transport system, 1773
vasodilatory response by elevated as determinant of oral glucose differential regulation in skeletal
D-glucose concentrations, 1497 tolerance in normal individuals, muscle of new model of NIDDM,
normal proinsulin responses, in mild 1324 1195
NIDDM subjects with subnormal Glucose transport effects of hyperinsulinemia and
insulin response, 162 in adipocytes, cellular insulin hyperglycemia on GLUT4 and
prevention of STZ-induced diabetes by resistance in gestational diabetes hexokinase Il mRNA and protein
D-glucose and 5-thio-D- glucose, caused by multiple defects in, in rat skeletal muscle and adipose
420 1773 tissue, 922
DIABETES: VOLUME 42 (1993) PAGE NUMBERS BY ISSUE
January, 1-212 April, 503-636 July, 941-1098 October, 1383-1547
February, 213-366 May, 637—800 August, 1099-1218 November, 1549-1689
March, 367-502 June, 801-940 September, 1219-1382 December, 1691-1882
SUBJECT INDEX 1993
metformin blockage of downregulation B-cell lines and fetal rat islets in direction of counterregulation during
of cell surface GLUT4 caused by primary culture, 1829 hypoglycemia by widespread
chronic insulin treatment of rat in glomeruli from diabetic rats, MRNA brain regions, 1253
adipocytes, 1159 expression of, 450 impairment of glucose
Glutamic acid decarboxylase insulinlike growth factor I-resistant counterregulation by alcohol
antibodies to, revelation of latent state in cartilage of diabetic rats intake during acute
autoimmune diabetes mellitus in ameliorated by hypophysectomy, insulin-induced hypoglycemia in
adults with non-insulin- dependent role of metabolism and, 463 IDDM, 1626
onset of disease, 359 transforming growth factor synthesis inhibitory effect of pregnancy on
differential expression of and expression in endocrine and counterregulatory hormone
of GAD, and GADg; in human, rat, exocrine pancreas, 746 responses to hypoglycemia in
and mouse pancreatic islets, Growth hormone, effect of on proinsulin awake rat, 1440
1799 levels in humans, 1082 Human leukocyte antigens
in rat and human islets, 485 Guanidines, prevention of diabetic association of HLA-A24 with complete
primary recognition of 65,000-M, rather vascular dysfunction by, inhibition of B-cell destruction in IDDM, 1086
than 67,000M, isoform of glutamic nitric oxide synthase versus class |, detection of insulin receptor
acid decarboxylase by advanced glycation end- product association with, 619
autoantibodies in IDDM, 631 formation and, 221 Hyperaminoacidemia, loss of potentiating
Glyceraldehyde, inhibition of
Guanosine triphosphatase, effect of hypoglycemia on giucagon
glucose-induced insulin secretion galanin-stimulated high- affinity response to, in IDDM, 550
through inactivation of glucokinase GTPase activity in plasma Hypercapnia, progressive, lack of effect
by, 1003
membranes from RINMS5F cells, 74 of naloxone on ventilatory response
Glycogen
to, in IDDM, 282
abnormal activation of synthesis in
Hyperglycemia
fibroblasts from subjects with H
antihyperglycemic effect of
NIDDM, evidence for abnormality
H7, sustained recovery of dehydroepiandrosterone analogue
specific to glucose metabolism,
583 Na*-K*-ATPase activity in mouse 16a-fluoro-5-androsten-17-one in
structure and segmental localization in sciatic nerve and, 257 diabetic mice, 1105
diabetic rat kidney, 891 Heart decrease of lipid oxidation and
Glycogen synthase, regulation of impairment of coronary vascular gluconeogenesis from lactate but
reserve and ACh-induced not fasting hyperglycemia or total
insulin-stimulated glycogen synthase
activity by overexpression of coronary vasodilation in diabetic hepatic glucose production by
glutamine: fructose-6 - phosphate patients with angiographically inhibition of lipolysis in NIDDM,
amidotransferase in rat-1 fibroblasts, normal coronary arteries and 1694
1289 normal left ventricular systolic effects in liver glycogen synthase
Glycogen synthase gene, simple tandem function, 1017 phosphatase activity in diabetic
repeat DNA polymorphism in, reversal of defect in mitrochondrial rat, 363
linkage to five markers in energy production in heart of effects on GLUT4 and hexokinase II
chromosome 19q, 930 chronically diabetic rat by mRNA and protein in rat skeletal
Glycolysis, resistance to hypoxia and physical training, 682 muscle and adipose tissue, 922
liability to hypoxic damage in Heat-shock protein, correlation of fibronectin-induced increase in
hypoglycemic peripheral nerves insulitis-caused redistribution of mesangial cell prostaglandin
and, 981 heat-shock protein HSP60 inside release and, 183
Glycosylation, requirement of Asn*9” or B-cells with induction of HSP60 hypoxia-induced sympathetic inhibition
Asn *'® for normal biosynthesis and autoantibodies, 908 of fetal plasma insulin response
processing of insulin receptors, 966 Hepatocytes to, 1621
Gold thioglucose, insulin response to inhibition of endocytosis in increased proinsulin/insulin ration in
intravenous glucose load during hepatocytes from diabetic rats, pancreas extracts of
development of obesity in gold 1303 hyperglycemic rats, 22
thioglucose-injected mice, 1153 organization of human GLUT2 glucose normalization by benfluorex, in
Granulocyte-colony stimulating factor, transporter gene, 773 STZ-induced diabetic, 564
improvement of impaired Hispanics, association of ethnicity and pseudohypoxia and, diabetic
bactericidal function in neutrophils polycystic ovary syndrome with complications and, 801
from STZ-induced rats by, 470 independent and additive decreases Hyperinsulinemia
Growth arrest-genes, increase of in insulin action in acute, effects on VLDL triglyceride and
expression by genotoxic agents, in Caribbean-Hispanic women, 1462 VLDL ApoB production in normal
rat pancreatic islets, 738 Histocompatibility antigens, isolated islet weight and obese individuals, 833
Growth factors of Langerhans transplantation in rat apolipoprotein E polymorphism
enhancement of glomerular collagen and, 90 modification of relation of
synthesis in diabetic rats by Hormonal counterregulation hyperinsulinemia to
transforming growth factor-B,, compromised, after recurrent hypertriglyceridemia, 1474
1673 short-term episodes of effects on GLUT4 and hexokinase II
expression of functional nerve growth insulin-induced hypoglycemia in mRNA and protein in rat skeletal
factor receptors in pancreatic IDDM, 610 muscle and adipose tissue, 922
DIABETES: VOLUME 42 (1993) PAGE NUMBERS BY ISSUE
January, 1-212 April, 503-636 July, 941-1098 October, 1383-1547
February, 213-366 May, 637—800 August, 1099-1218 November, 1549-1689
March, 367—502 June, 801-940 September, 1219-1382 December, 1691-1882
SUBJECT INDEX 1993
effects on muscle fiber composition insulin in diabetic autonomic nephropathy in, impact of arterial
and capillarization in rats, 1073 neuropathy, 1055 blood pressure and albuminuria in
Hypertension Hypoxia progression of, 715
incidence of NIDDM and impaired hyperglycemia pseudohypoxia and normalization of neuroendocrine
glucose tolerance in, 154 diabetic complications, 801 responses to, symptoms of, and
insulin resistance in spontaneously insulin secretion by isolated rat and cognitive function during
hypertensive rats, 1364 canine islets of Langerhans, 12 hypoglycemia in short-term IDDM,
in vivo glucose metabolism in obese resistance to, liability to hypoxic by prevention of hypoglycemia,
and NIDDM subjects with or damage in hypoglycemic 1683
without hypertension, 764 peripheral nerves and, glycolysis North-American twins with, genetic,
Hypertriglyceridemia, apolipoprotein E and, 981 etiological, and clinical
polymorphism modification of sympathetic inhibition of fetal plasma significance of disease
relation of hyperinsulinemia to insulin response to hyperglycemia concordance according to age,
hypertriglyceridemia, 1474 induced by, 1621 zygosity, and interval after
diagnosis in first twin, 1351
Hypoglycemia
awareness of. See Symptom number of bursts of muscle
awareness I sympathetic nerve activity in IDDM
direction of counterregulation during IDDM as sign of autonomic neuropathy,
aberrant distribution of CD4 and CD8 1376
by widespread brain regions,
1253 lymphocyte subsets in pancreatic B-cell repair in early IDDM,
recent-onset IDDM patients, 862 1383
effects of differing insulin levels on
association of HLA-A24 with complete prediction of, 213
thoo,r mino nnaolr maaln d hummeatanbso,l ic2 63r esponse B-cell destruction in, 1086 recognition of distinct islet antigens by
autoantibodies in, primary recognition cytoplasmic islet cell antibodies
iatrogenic, in IDDM, 1691 of 65,000-M, rather than 67,000M, in, 1642
impairment of glucose
isoform of glutamic acid recurrent short-term episodes of
counterregulation by alcohol decarboxylase by, 631 insulin-induced hypoglycemia in,
intake during acute characterization of insulin compromised hormonal
insulin-induced hypoglycemia in autoantibodies in relatives of counterregulation, symptom
IDDM, 1626
patients with, 1202 awareness, and
induction of hypoglycemia decreased risk of IDDM in offspring of neurophysiological function after,
unawareness by asymptomatic mothers who acquire diabetes 610
nocturnal hypoglycemia, 1233 during adrenarchy, 1433 regulation of apolipoprotein
inhibitory effect of pregnancy on design of trails for prevention of, 941 A-l-containing lipoproteins in,
counterregulatory hormone driving decrements in IDDM during 1281
responses to, in awake rat, 1440 moderate hypoglycemia, 239 reversal of tolerance to IDDM induced
liability to hypoxic damage in early introduction of dairy products by CD4 antibodies in nonobese
peripheral nerves, glycolysis and, associated with increased risk of, diabetic mice by
981 in Finnish children, 1786 cyclophosphamide, 1601
loss of potentiating effect on glucagon endothelium-dependent vascular risk of, conferred by 5’ insulin gene
response to hyperaminoacidemia relaxation in, 148 polymorphism independently of
in IDDM and, 550 genetic predisposition and risk of, HLA class II susceptibility, 851
moderate, driving decrements in IDDM early exposure to cow's milk and simultaneous coexpression of naive
during, 239 solid foods in infancy and, 288 and memory lymphocyte markers
normalization of neuroendocrine HLA-DQA1 and DQB1 gene at diagnosis of, 127
responses to, symptoms of, and polymorphisms in IDDM patients transcription factor jun-B as target of
cognitive function during from central Italy and their use for autoreactive cells in, 626
hypoglycemia in short-term IDDM, risk prediction, 1173 ventilatory response to progressive
by prevention of hypoglycemia iatrogenic hypoglycemia in, 1691 hypercapnia in, lack of effect of
1683 impaired vasodilator response to atrial naloxone on, 282
recurrent short-term episodes of natriuretic factor in, 1454 weight gain in, intensive insulin
insulin-induced hypoglycemia in impairment of glucose therapy and, 1700
IDDM, compromised hormonal counterregulation by alcohol Immunodeficiency, adoptive transfer of
counterregulation, symptom intake during acute diabetes into immunodeficient NOD
awareness, and insulin-induced hypoglycemia in, mice, 44
neurophysiological function after, 1626 Inositol
610 induced by thymectomy and antagonism of glucagon activation of
severe, in adult patients with irradiation, in rats, 571 glycogen phosphorylase by
insulin-treated diabetes, 341 loss of potentiating effect of inositol glycan phosphate derived
Hypophysectomy, insulinlike growth hypoglycemia on glucagon from human erythrocyte
factor I-resistant state in cartilage of response to hyperaminoacidemia acetylcholinesterase glycolipid
diabetic rats ameliorated by, role of in, 550 anchor and inositol cyclic
metabolism and, 463 muscie sympathetic nerve activity in, 1,2-phosphate, 1318
Hypotension, arterial, mechanisms after reduction before overt neuropathy, effects of high glucose concentrations
therapeutic dose of subcutaneous 375 and epalrestat on sorbitol and
DIABETES: VOLUME 42 (1993) PAGE NUMBERS BY ISSUE
January, 1-212 April, 503-636 July, 941-1098 October, 1383-1547
February, 213-366 May, 637-800 August, 1099-1218 November, 1549-1689
March, 367-502 June, 801-940 September, 1219-1382 December, 1691-1882
SUBJECT INDEX 1993
myo-inositol metabolism in localization of IDDM susceptibility role of glucose-6- phosphatase in
cultured rabbit aortic smooth locus to variable tandem repeat action on hepatic glucose
muscle cells, 1594 region flanking insulin gene, 1708 production in rat, 1614
mechanisms for D-glucose inhibition of mechanisms of arterial hypotension Insulin-dependent diabetes. See IDDM
myo-inositol influx into rat lens, after therapeutic dose of Insulin gene
1737 subcutaneous insulin in diabetic localization of IDDM susceptibility
myo-inositol transport in autonomic neuropathy, 1055 locus to variable tandem repeat
region flanking, 1708
glucose- desensitized rat islets, microdialysis measurement of
1392 concentration in subcutaneous risk to IDDM conferred by 5’ insulin
gene polymorphism independently
reduced motor nerve conduction interstitial fluid, endothelial barrier
of HLA class II susceptibility, 851
velocity and Na*-K*-ATPase and, 1469
somatostatin inhibition of gene
activity in rats maintained on microtiter well assay system to expression through
L-fucose diet, reversal by measure insulin activation of posttranscriptional mechanism in
myo-inositol supplementation, insulin receptor kinase in intact hamster islet cell line, 244
1401 human mononuclear cells, 883 Insulinlike growth factor |
upregulation of myo-inositol transport, normal proinsulin responses to in extreme insulin resistance
compensation for competitive glucose in mild NIDDM subjects syndromes, 696
inhibition by glucose and, 1119 with subnormal insulin response, resistant state in cartilage of diabetic
Inositol glycan, insulin-induced 162 rats ameliorated by
generation in rat adipocytes, 988 proteolytic processing of proinsulin to, hypophysectomy, role of
Insulin metabolism of des(64,65)-human metabolism and, 463
action of, effects of epinephrine on, proinsulin in rat and, 1407 Insulinoma
interaction with aging, 307 regulation of insulin-stimulated murine insulinoma cell line with normal
altered distribution between glycogen synthase activity by glucose-regulated insulin
intravascular and interstitial overexpression of secretion, 901
compartments in STZ-induced glutamine:fructose- 6 - phosphate sulfonylurea- binding sites and
diabetic rats, 1528 amidotransferase in rat-1 ATP-sensitive K* channels in a-TC
characterization of insulin fibroblasts, 1289 glucagonoma and B-TC
autoantibodies in relatives of relationship to cardiovascular risk insulinoma cells, 1760
patients with IDDM, 1202 factors in nondiabetic subjects, Insulin-receptor promotor region,
deficiency of, effects in liver glycogen 1297 GC-rich, nuclear- protein binding
synthase phosphatase activity in sensitivity of glucose and amino acid analysis of, 66
diabetic rat, 363 metabolism to, in NIDDM, 1868 Insulin receptors
dynamics of hepatic and peripheral severe hypoglycemia and intelligence characterization of cDNA, gene, and
effects of, common rate-limiting in adult patients with chromosomal localization of
step in vivo suggested by, 296 insulin-treated diabetes, 341 human skeletal muscle insulin
effect of fasting on insulin-stimulated stimulation of hydrolysis of receptor substrate-1, 1041
defective kinase activity and insulin
glucose uptake and intracellular plasmanylinositgloylc-an and
resistance caused by Ala’
glucose metabolism in conscious phosphatidylinosigtloylca-n in rat
rats, 757 adipocytes by, 988 mutation in kinase domain of,
1837
effect on tissue kallikrein and tonin stimulation of production and secretion
levels in submandibular glands of of endothelin from bovine detection of association with class |
human leukocyte antigen
STZ-induced diabetic rats, 113 endothelial cells by, 351
molecules in cell surfaces, 619
effects of differing levels on hormonal thoracic duct lymph and dynamics of,
differences in ratio of RNA encoding of
and metabolic response to splanchnic and muscle tissue isoforms between control and
hypoglycemia in normal humans, and, 720
NIDDM patients, 675
263 transport across rabbit nasal mucosa induction of insulin resistance of
effects of physiological increments in in vitro induced by
glucose transport and glycogen
plasma concentrations on didecanoyl-L-a- synthesis in isolated rat skeletal
synthesis of hepatic proteins in phosphatidylcholine, 1032 muscles by pre-exposure to
normal humans, 995 Insulin actions glucosamine, 1333
effects on fatty acid reesterification in association of ethnicity and polycystic insulin receptor substrate-1 and insulin
healthy subjects, 1588 ovary syndrome with independent signaling, 643
enhancement of lipolysis and and additive decreases in, in methionine for valine substitution in
activation of partially purified Caribbean-Hispanic women, 1462 exon 17 of insulin receptor gene
hormone-sensitive lipase by impact of obesity on, in NIDDM, 405 in pedigree with familial NIDDM,
chronic exposure of rat fat cells linkage of chromosomal marker on 4q 429
to, 1415 with putative gene determining microtiter well assay system to
failure to induce hydrolysis of glycosyl maximal action in Pima Indians, measure insulin activation of
phosphatidylinositol in rat fetal 514 insulin receptor kinase in intact
hepatocytes, 1262 pharmacodynamics and activity of human mononuclear cells, 883
glucose transport in human skeletal intranasally administered insulin in muscle-specific expression in
muscle and, 191 healthy male volunteers, 1649 transgenic mice, 206
DIABETES: VOLUME 42 (1993) PAGE NUMBERS BY ISSUE
January, 1-212 April, 503-636 July, 941-1098 October, 1383-1547
February, 213-366 May, 637-800 August, 1099-1218 November, 1549-1689
March, 367-502 June, 801-940 September, 1219-1382 December, 1691-1882
SUBJECT INDEX 1993
requirement of Asn°9’ or Asn 4'® for inhibition of glucose-induced secretion calcium channel mRNA expression in
normal biosynthesis and through inactivation of glucokinase rat, downregulation after glucose
processing of, 966 by glyceraldehyde, 1003 infusion and, 948
Insulin resistance by isolated rat and canine islets of differential expression of GAD,. and
in aging, relationship to abdominal Langerhans, effect of hypoxia on, GADg; in human, rat, and mouse
obesity, 273 12 islets, 1799
in blacks with NIDDM, 444 lack of effect of deferoxamine therapy differential expression of glutamic acid
caused by Ala'°48—> mutation in kinase on, in individuals with NIDDM and decarboxylase in rat and human
domain of insulin receptor, 1837 elevated serum ferritin, 544 islets, 485
murine insulinoma cell line with normal effect of STZ administration on islet
cellular, in gestational diabetes caused
glucose-regulated insulin allograft and allograft survival in
by multiple defects in adipocyte
secretion, 901 NOD mice, 324
glucose transport system, 1773
oscillatory, after pancreas transplant, effects of monomethylsuccinate and
as determinant of oral glucose 855 glucose on insulin secretion from
tolerance in normal individuals, reduction by repeated low doses of perfused rat islets, 843
1324
streptozocin, impairment of fluorescence digital image analysis of
hepatic, reversal by benfluorex, in glucose effectiveness and lack of glucose-induced [Ca?*],
STZ-induced diabetic rats, 564 induction of insulin resistance in oscillations in mouse islets, 1210
inducement by diet and amelioration dogs and, 475 function in nondiabetic and diabetic
with benfluorex in rat, 457 retinoic acid receptor, cytosolic BB rats, 1310
induction of insulin resistance of retinol-binding and retinoic GABA production in rat islets, 1506
glucose transport and glycogen acid-binding protein mRNA glucose-induced amplitude regulation
synthesis in isolated rat skeletal transcripts and proteins in rat of pulsatile insulin secretion from
muscles by pre-exposure to insulin-secretion cells, 1109 individual islets, 670
glucosamine, 1333 Insulin sensitivity increase of expression of growth arrest
insulinlike growth factor | therapy for quantification of relationship between and DNA damage-inducible
patients with extreme insulin insulin sensitivity and B-cell genes gadd 153 and gadd 45 by
resistance syndromes, 696 function in human subjects, 1663 genotoxic agents in, 738
in spontaneously hypertensive rats, reduced sample number for influence of islet amyloid polypeptide
1364 calculation of insulin sensitivity and 8-37 fragment of islet amyloid
stimulation of glucose transport, and glucose effectiveness from polypeptide on insulin release
glucose transporter translocation, minimal model, 250, 1635 from perfused rat islets, 330
and dephosphorylation in Insulin signaling insulin secretion, myo-inositol
insulin-resistant rat adipocytes in G-protein specificity in signaling transport, and Na*-K*-ATPase in
vitro by glimepiride, 1852 pathways that mobilize calcium in glucose- desensitized rat islets,
Insulin secretion insulin-secreting B-TC3 cells, 1878 1392
amplification by lipid messengers, 367 insulin receptor substrate-1 and insulin secretion by isolated rat and
arginine vasopressin and oxytocin proteins with SH2 domains and, canine islets, effect of hypoxia on,
643 12
effects in mouse pancreatic
B-cells, 914 Insulin therapy interleukin-1 interaction with B-cells of,
intensive, weight gain in IDDM and, 56
as determinant of oral glucose
1700 islet cell DNA as target of inflammatory
tolerance in normal individuals,
1324 pharmacodynamics and activity of attack by nitric acid, 496
intranasally administered insulin in prevention of rejection of islet
effects of epinephrine on, interaction
healthy male volunteers, 1649 xenografts (rat to mouse) by tumor
with aging, 307 Insulitis, association of faulty major necrosis factor-a, 651
effects of monomethylsuccinate and
histocompatibility complex class II proinsulin conversion in, kinetics of,
glucose on secretion from I-E expression with autoimmunity in 933
perfused rat islets, 843 diverse strains of mice, 1166 prolongation of islet allograft survival
glucagonlike peptide-1 and control of Intelligence, in adult patients with by MHC class | deficiency, 1520
secretion in normal state and insulin-treated diabetes, 341 recognition of distinct islet antigens by
NIDDM, 1219
Interleukin-1 cytoplasmic islet cell antibodies in
in glucose- desensitized rat islets, 1392 interaction with islet B-cells, 56 IDDM but not in stiff man
glucose-induced amplitude regulation prolongation of mouse islet allograft syndrome, 1642
of pulsatile secretion from survival by treatment with regulation of amyloid polypeptide in
individual pancreatic islets, 670 interleukin-1 receptor antagonist, human islets, 1514
GLUT2 expression and function in 1845 signals derived from glucose
B-cells of GK rats with NIDDM, selective pancreatic B-cell production metabolism required for glucose
dissociation between reductions in of tumor necrosis factor-a induced regulation of islet GLUT2 mRNA
glucose transport and by, 1026 and protein, 1273
glucose-stimulated insulin International International Immunology somatostatin inhibition of insulin- gene
secretion and, 1065 and Diabetes Workshop, 1099 expression through
G-protein specificity in signaling Irradiation, IDDM induced by, in rats, posttranscriptional mechanism in
pathways that mobilize calcium in 571 hamster islet cell line, 244
insulin-secreting B-TC3 cells, 1878 Islets of Langerhans transplantation of, in rat
DIABETES: VOLUME 42 (1993) PAGE NUMBERS BY ISSUE
January, 1-212 April, 503-636 July, 941-1098 October, 1383-1547
February, 213-366 May, 637-800 August, 1099-1218 November, 1549-1689
March, 367-502 June, 801-940 September, 1219-1382 December, 1691-1882
SUBJECT INDEX 1993
histocompatibility antigens in, 90 Lipoprotein(s), apolipoprotein fibronectin-induced increase in
insulin secretory function in relation A-l-containing, regulation in IDDM, prostaglandin release by,
to transplanted islet mass and, 1281 hyperglycemia and PKC inhibition
98 Liver and, 183
ecrease of lipid oxidation and grown in high- glucose medium,
gluconeogenesis from lactate but accumulation of fibronectin by,
J
not fasting hyperglycemia or total mediation by protein kinase C,
Japanese
association of polymorphic hepatic glucose production by 118
microsatellite repeat markers at inhibition of lipolysis in NIDDM, mediation of increased fibronectin
glucokinase gene locus with 1694 accumulation by mesangial cells
NIDDM in, 1147 effects of physiological increments in grown in high- glucose medium by
sequence variations of glucokinase plasma insulin concentrations on protein C, 118
gene in Japanese subjects with synthesis of hepatic proteins in proteoglycans produced by, effect of
NIDDM, 1133 normal humans, 995 glucose on, 1815
jun-B transcription factor, as target of failure of insulin to induce hydrolysis of Metalloprotease, decreased activity in
autoreactive cells in IDDM, 626 glycosy! phosphatidylinositol in rat STZ-induced diabetes in rats, 1425
fetal hepatocytes, 1262 Metformin, blockage of downregulation
impaired regulation of hepatic of cell surface GLUT4 caused by
fructose-1,6-biphosphatase in chronic insulin treatment of rat
Kallikrein, in submandibular glands of New Zealand obese mouse model adipocytes by, 1159
$TZ-induced diabetic rats, effects of of NIDDM, 1731 Methionine, for valine substitution in exon
insulin and, 113 inhibition of endocytosis in 17 of insulin receptor gene in
Kidney. See also Glomeruli; Nephropathy hepatocytes from diabetic rats, pedigree with familial NIDDM, 429
decreased activity of glomerular 1303 Methylamine, oxidative deamination by
cathepsin and metalloprotease in role of glucose-6-phosphatase in semicarbazide-sensitive amine
STZ-induced diabetes in rats, action of insulin on hepatic oxidase leading to cytotoxic damage
1425 glucose production in rat, 1614 in endothelial cells, 594
enhancement of glomerular collagen transplantation of, metabolic effects of Methylguanine, repair of
synthesis in diabetic rats by cyclosporin A and FK 506 in O®-methylguanine in rat B-cells after
transforming growth factor-B,, transplant recipients, 1753 exposure to N-methyl-N-nitrosourea,
1673
Liver glycogen synthase phosphatase, 1187
glycogen structure and segmental opposite effects of hyperglycemia Mitochondria, reversal of defect in
localization in diabetic rat kidney, and insulin deficiency on, in diabetic mitrochondrial energy production in
891 rat, 363 heart of chronically diabetic rat by
neuropathy following successful Lymphocytes. See also CD8* T-cells; physical training, 682
pancreas and kidney CD4* T-cells Monomethylsuccinate, effects on insulin
transplantation, 1482 endothelial cell-binding properties of secretion frorn perfused rat islets,
Kinase, defective kinase activity and iymphocytes infiltrated into human 843
insulin resistance caused by diabetic pancreas, 1656 mRNA
Ala'°4®-s mutation in kinase domain
Lymphopenia, transcription and calcium channel mRNA expression in
of insulin receptor, 1837 translation of RT6* gene in rat pancreatic islets,
lymphopenic diabetes- prone BB downregulation after glucose
rats, 688 infusion and, 948
Laminin, inhibition of neurite outgrowth Lymphotoxin, prevention of autoimmune effects of hyperinsulinemia and
by nonenzymatic glycosylation of, diabetes in NOD mice by, 398 hyperglycemia on GLUT4 and
509 hexokinase Il mRNA and protein
Lipase, enhancement of lipolysis and M in rat skeletal muscle and adipose
activation of partially purified Major histocompatibility complex tissue, 922
hormone-sensitive lipase by chronic association of faulty major expression of growth factors in
exposure of rat fat cells to insulin, histocompatibility complex class II glomeruli from diabetic rats, 450
1415 |-E expression with autoimmunity retinoic acid receptor, cytosolic
Lipid(s) in diverse strains of mice, 1166 retinol- binding and retinoic
in children, 1010 prolongation of islet allograft survival acid-binding protein MRNA
decrease of lipid oxidation and by MHC class | deficiency, 1520 transcripts and proteins in rat
gluconeogenesis from lactate but MDL 29,311, 1179 insulin-secretion cells, 1109
not fasting hyperglycemia or total prevention of diabetes in nonobese signals derived from glucose
hepatic glucose production by diabetic and multiple-lodwo-se metabolism required for glucose
inhibition of lipolysis in NIDDM, STZ-injected mice by, 1721 regulation of pancreatic islet
1694 Memory lymphocyte markers, GLUT2 mRNA and protein, 1273
MDL 29,311 and, 1179 simuitaneous expression with naive Muscle
Lipid messengers, amplification of insulin lymphocyte markers at diagnosis of effects of hyperinsulinemia on muscle
secretion by, 367 IDDM, 127 fiber composition and
Lipolysis, enhancement by chronic Mesangial cells capillarization in rats, 1073
exposure of rat fat cells to insulin, effect of high glucose on type IV number of bursts of muscle
1415 collagen production by, 170 sympathetic nerve activity in IDDM
DIABETES: VOLUME 42 (1993) PAGE NUMBERS 8Y ISSUE
January, 1-212 April, 503-636 July, 941-1098 October, 1383-1547
February, 213-366 May, 637—800 August, 1099-1218 November, 1549-1689
March, 367-502 June, 801-940 September, 1219-1382 December, 1691-1882